128 related articles for article (PubMed ID: 9891193)
1. Current experience with tacalcitol ointment in the treatment of psoriasis.
Gollnick H; Menke T
Curr Med Res Opin; 1998; 14(4):213-8. PubMed ID: 9891193
[TBL] [Abstract][Full Text] [Related]
2. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
3. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
6. Topical tacalcitol treatment for psoriasis.
Harrison PV
Hosp Med; 2000 Jun; 61(6):402-5. PubMed ID: 10962655
[TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers.
Schlotmann K; Ortland C; Neumann NJ; Ruzicka T; Lehmann P
Contact Dermatitis; 2000 May; 42(5):260-3. PubMed ID: 10789839
[TBL] [Abstract][Full Text] [Related]
8. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
Lambert J; Trompke C
Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
[TBL] [Abstract][Full Text] [Related]
9. Profile of clinical efficacy and safety of topical tacalcitol.
Leone G; Pacifico A
Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
[TBL] [Abstract][Full Text] [Related]
10. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
12. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.
Kawaguchi M; Mitsuhashi Y; Kondo S
J Dermatol; 2003 Nov; 30(11):801-4. PubMed ID: 14684937
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis.
Dua I; Aggarwal K; Jain VK
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
[TBL] [Abstract][Full Text] [Related]
17. High-concentration (20 μg g⁻¹ ) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial.
Choi JW; Choi JW; Kwon IH; Youn JI
Br J Dermatol; 2010 Jun; 162(6):1359-64. PubMed ID: 20302582
[TBL] [Abstract][Full Text] [Related]
18. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
Katayama I; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(6):553-7. PubMed ID: 12459526
[TBL] [Abstract][Full Text] [Related]
19. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study.
Helfrich YR; Kang S; Hamilton TA; Voorhees JJ
Br J Dermatol; 2007 Aug; 157(2):369-74. PubMed ID: 17596167
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
